Assetmark, Inc Tekla Life Sciences Investors Transaction History
Assetmark, Inc
- $41.6 Billion
- Q2 2025
A detailed history of Assetmark, Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Assetmark, Inc holds 265 shares of HQL stock, worth $4,452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265Holding current value
$4,452% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
87Shares Held
9.87MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.02MShares$50.7 Million0.99% of portfolio
-
Penserra Capital Management LLC Orinda, CA794KShares$13.3 Million0.16% of portfolio
-
Morgan Stanley New York, NY766KShares$12.9 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A6451KShares$7.58 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY431KShares$7.24 Million0.23% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...